Cas:951884-42-7 5-Bromo-4-isopentylpyrimidine manufacturer & supplier

We serve Chemical Name:5-Bromo-4-isopentylpyrimidine CAS:951884-42-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Bromo-4-isopentylpyrimidine

Chemical Name:5-Bromo-4-isopentylpyrimidine
CAS.NO:951884-42-7
Synonyms:5-bromo-4-(3-methylbutyl)pyrimidine
Molecular Formula:C9H13BrN2
Molecular Weight:229.11700
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:25.78000
Exact Mass:228.02600
LogP:2.82770

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-bromo-4-(3-methylbutyl)pyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-bromo-4-(3-methylbutyl)pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-bromo-4-(3-methylbutyl)pyrimidine Use and application,5-bromo-4-(3-methylbutyl)pyrimidine technical grade,usp/ep/jp grade.


Related News: Any South Korean citizen returning home who has been in Hubei Province within the past two weeks will be subject to 14 days of self-quarantine and monitoring, the government said. 5-Bromo-4-isopentylpyrimidine manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 5-Bromo-4-isopentylpyrimidine supplier Active pharmaceutical ingredients directly impact disease. 5-Bromo-4-isopentylpyrimidine vendor Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 5-Bromo-4-isopentylpyrimidine factory Active pharmaceutical ingredients directly impact disease.